Brief: Shanghai Bio-Heart Biological Technology Posts HY Loss For Period RMB95.1 Mln
Aug 11 (Reuters) - Shanghai Bio-heart Biological
Technology Co Ltd 2185.HK :
* HY LOSS FOR PERIOD RMB95.1 MILLION VERSUS LOSS RMB115.6
MILLION
* HY OTHER INCOME AND GAINS RMB5.8 MILLION VERSUS RMB10.2
MILLION
Source text for Eikon: ID:nHKS4xy5Sd
Further company coverage: 2185.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai Bio-heart Biological Technology
See all newsBrief: Shanghai Bio-Heart Biological Technology Says NMPA Approves Bioheart Bioabsorbable Drug-Eluting Stents
Brief: Shanghai Bio-Heart Biological Technology Says Iberis Rdn System Completes Registration In Vietnam
Brief: Shanghai Bio-Heart Biological Technology Says Iberis RDN System Completed Registration In Thailand
Brief: Shanghai Bio-Heart Biological Technology Says Iberis RDN System Completes Registration With MHRA In UK
Brief: Shanghai Bio-Heart Biological Technology's Controlling Shareholder Increases Shareholding